The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Ravi Menon - Macquarie Research - Analyst
: Good numbers. Congratulations on that. I just wanted to ask you about the U.S. government business, that's shown good traction. But can you
describe how the health ministry's customs (inaudible). The other parts, are there any indications of new programs starting? That's the first question.
And second, in the U.S., it's flat quarter-on-quarter. And I think last quarter, we had won a deal to start an offshore development center for a client.
So while expecting to see some of that ramp up, has that got delayed? Or is that already in the numbers?
Question: Ravi Menon - Macquarie Research - Analyst
: No, Hiral, it was about the U.K. government business outside of...
Question: Ravi Menon - Macquarie Research - Analyst
: Yes. So you said that there are -- you started a new biometric program, but how is the pipeline looking there beyond this?
Question: Ravi Menon - Macquarie Research - Analyst
: And just a longer-term question on the Oracle side. I thought that the work that the Oracle did was very project-oriented and would be able to do
a lot of them, but then that's a constant treadmill of projects that we are on. Has that changed? Or how would we see that Oracle business -- you
were talking about that growing above company average, is that predicated on getting the new pipeline of larger deals? Or are we moving to a
more annuity-oriented model through that?
Question: Ravi Menon - Macquarie Research - Analyst
: Great. One last question, if I may. On the U.S. environment, we've been hearing that there have been project put on hold, customers are starting
to show some reluctance to commit to CapEx. Are you starting to see any of that given your customer base is a little bit more smaller companies?
Would there be more at risk in this environment?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
APRIL 19, 2023 / 11:30AM, MAST.NS - Q4 2023 Mastek Ltd Earnings Call
Question: Pratap Maliwal - Mount Intra Finance Pvt Ltd - Analyst
: I think most questions have been answered. But I think last quarter, you had called out that there's been some greater than 5 million deals and a
couple of them are maybe in the pipeline for Q4. So is there any update here? Have you won any of those deals? Any traction on that part?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
APRIL 19, 2023 / 11:30AM, MAST.NS - Q4 2023 Mastek Ltd Earnings Call
| 
